Custom Peptide Libraries
Cell Signaling Technology SARS-CoV-2 Spike Protein Serological IgA ELISA Kit 5 Kit
SARS-CoV-2 Spike Protein Serological IgA ELISA Kit 5 Kit
Cell Signaling Technology SARS-CoV-2 Spike Protein Serological IgM ELISA Kit 5 Kit
SARS-CoV-2 Spike Protein Serological IgM ELISA Kit 5 Kit
Genscript Corporation SARS-CoV-2 Spike protein RBD
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2) the receptor on target cells It is believed that SARS-CoV-2 Spike Protein (RBD) has potential value for the diagnosis of the virus
Genscript Corporation SARS-CoV-2 Spike protein RBD
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases The spike protein mutation N501Y is one of six key contact residues within the receptor-binding domain (RBD) and has been identified as increasing binding affinity to human and murine ACE2
Medchemexpress LLC Protein E7 HPV16 H 100ug
HPV16 E7 is a viral phosphoprotein with oncogenic activity belonging to the human papillomavirus early protein family HPV16 E7 activates the cell cycle by releasing E2F through proteasome degradation of pRB HPV16 E7 can cooperate with E6 to immortalize cells and neutralize the toxicity of E5 while activating the AP-1/NF- B pathway and downregulating E-cadherin to enhance migration and invasion making it a core target for cervical cancer Protein E7 HPV (His) is a recombinant HPV E7 protein expressed from E coli with an N-6 His tag
Cayman Chemical 1 2 3TrIdocosahexaenoyl Glyc
A selective inhibitor of mutant EGFR that exhibits a 298-fold increase in potency compared with wild-type EGFR oral administration at 500 mg/kg regresses tumors with EGFR-active and T790M mutations in a xenograft model
Cayman Chemical 123 TrIdocosaheaenyl Glyc 50mg
A monoclonal antibody-derived tetrapeptide that acts as a partial agonist at the glycine site of the NMDA receptor active in vivo and readily passes the BBB blocks neuropathic pain enhances learning and memory and significantly reduces anxiety in animals
Cayman Chemical 1 2 3TrIdocosahexaenoyl Glyc
A selective inhibitor of mutant EGFR that exhibits a 298-fold increase in potency compared with wild-type EGFR oral administration at 500 mg/kg regresses tumors with EGFR-active and T790M mutations in a xenograft model
Cayman Chemical 123 TrIdocosaheaenyl Glyc 25mg
An analytical reference standard major metabolite of stanozolol intended for research and forensic applications